Page last updated: 2024-09-04

resiquimod and Bronchial Hyperreactivity

resiquimod has been researched along with Bronchial Hyperreactivity in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahrens, B; Hamelmann, E; Joachim, RA; Kallinich, T; Quarcoo, D; Stock, P; Weixler, S1
Alber, G; Bauer, S; Garn, H; Renz, H; Sel, S; Wegmann, M1

Other Studies

2 other study(ies) available for resiquimod and Bronchial Hyperreactivity

ArticleYear
Resiquimod, a new immune response modifier from the family of imidazoquinolinamines, inhibits allergen-induced Th2 responses, airway inflammation and airway hyper-reactivity in mice.
    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2004, Volume: 34, Issue:8

    Topics: Allergens; Animals; Asthma; Bronchi; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Female; Imidazoles; Immunologic Factors; Interferon-gamma; Interleukin-12; Interleukin-4; Interleukin-5; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Ovalbumin; Th2 Cells

2004
Immunomodulatory effects of viral TLR ligands on experimental asthma depend on the additive effects of IL-12 and IL-10.
    Journal of immunology (Baltimore, Md. : 1950), 2007, Jun-15, Volume: 178, Issue:12

    Topics: Animals; Antibodies; Antiviral Agents; Asthma; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cytokines; Female; Imidazoles; Immunoglobulin E; Immunoglobulin G; Immunosuppression Therapy; Interleukin-10; Interleukin-12; Interleukin-12 Subunit p35; Ligands; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Mutant Strains; Ovalbumin; Poly I-C; Toll-Like Receptor 3; Toll-Like Receptor 7

2007